Quality improvement project helps identify IBD diagnosis delays

Time to patient presentation was the largest component of time to diagnosis of inflammatory bowel disease, according to research published in Alimentary Pharmacology & Therapeutics.
James R. Goodhand, of Exeter IBD and Pharmacogenetics Research Group in the United Kingdom, and colleagues wrote that a timely diagnosis in IBD is critical for management of the disease.
“Contemporary studies of the time to diagnosis of IBD from the UK, where healthcare is free at the point-of-access and general practitioners act as gatekeepers to secondary care services, are lacking,” they wrote. “Most

Source link

Related posts

Colectomy Appears to Increase Later Risk of Type 2 Diabetes


CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263


Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-based Therapies for Inflammatory Bowel Diseases


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World